Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RCT of retreatment with artemisinin-based combination therapy for uncomplicated falciparum malaria in young children
PACTR201203000351114Recruiting
- Sponsor
- Jean-Pierre Van geertruyden
- Start
- Mar 2012
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 2
01
Overview
Randomised trial in Malaria comparing Artemether-lumefantrine, Artesunate-amodiaquine and Quinine + clindamycin (3 arms). Primary endpoint: PCR-adjusted efficacy at day 28. Started Mar 2012; status: recruiting.
02
Drugs
artemether + lumefantrineartesunate + amodiaquinequinineclindamycin
03
Conditions
Malaria
Beyond the preview
Go deeper on PACTR201203000351114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201203000351114.